Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Kevin Winthrop and Joel Gelfand.
Kevin Winthrop
Connection Strength
0.891
Joel Gelfand
  1. Effect of anti-tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis-A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic. J Am Acad Dermatol. 2021 01; 84(1):161-163.
    View in: PubMed
    Score: 0.225
  2. Reply to: "Do IL-17 inhibitors increase risk of respiratory tract infections?" J Am Acad Dermatol. 2020 10; 83(4):e305-e306.
    View in: PubMed
    Score: 0.223
  3. The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic. J Am Acad Dermatol. 2020 11; 83(5):1523-1526.
    View in: PubMed
    Score: 0.223
  4. The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic. J Am Acad Dermatol. 2020 08; 83(2):677-679.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.